Fortrea Holdings Inc. (NASDAQ:FTRE) Given Consensus Rating of "Hold" by Analysts

Key Points

• "Hold" consensus from 11 analysts (1 sell, 5 hold, 5 buy) with an average 12‑month price target of $16.05, while broker targets range widely from $11 to $25.
• Fortrea's latest quarter missed expectations (EPS $0.09 vs. $0.16; revenue $660.5M vs. $665.2M), and the company shows a negative net margin of 36.21% and a negative P/E (-1.12) despite a $1.15B market cap and a 52‑week range of $3.97–$18.67.
• CFO Jill G. McConnell sold 5,061 shares at about $9.07, reducing insider ownership to 0.38%, even as several institutional investors have recently increased or initiated positions.

Shares of Fortrea Holdings Inc. (NASDAQ:FTRE - Get Free Report) have been assigned a consensus rating of "Hold" from the eleven analysts that are covering the company, Marketbeat reports. One analyst has rated the stock with a sell rating, five have issued a hold rating and five have issued a buy rating on the company. The average 12 month price objective among brokers that have updated their coverage on the stock in the last year is $16.05.

Several research analysts have recently issued reports on FTRE shares. Robert W. Baird reduced their price objective on Fortrea from $19.00 to $16.00 and set an "outperform" rating for the company in a research note on Friday, February 27th. Mizuho set a $15.00 price objective on Fortrea in a research note on Friday, January 9th. Barclays reduced their price objective on Fortrea from $12.00 to $11.00 and set an "equal weight" rating for the company in a research note on Tuesday, April 14th. Truist Financial set a $22.00 price objective on Fortrea and gave the stock a "buy" rating in a research note on Thursday, January 8th. Finally, Evercore set a $25.00 price objective on Fortrea and gave the stock an "outperform" rating in a research note on Tuesday, January 6th.

Fortrea Price Performance

Shares of NASDAQ FTRE opened at $12.18 on Monday. The company has a debt-to-equity ratio of 1.86, a quick ratio of 0.98 and a current ratio of 0.98. The company has a market cap of $1.15 billion, a PE ratio of -1.12, a P/E/G ratio of 0.45 and a beta of 1.92. The business has a 50-day simple moving average of $9.88 and a two-hundred day simple moving average of $12.46. Fortrea has a fifty-two week low of $3.97 and a fifty-two week high of $18.67.

Fortrea (NASDAQ:FTRE - Get Free Report) last issued its quarterly earnings results on Thursday, February 26th. The company reported $0.09 earnings per share for the quarter, missing the consensus estimate of $0.16 by ($0.07). Fortrea had a positive return on equity of 6.23% and a negative net margin of 36.21%.The business had revenue of $660.50 million during the quarter, compared to analyst estimates of $665.22 million. As a group, equities analysts expect that Fortrea will post 0.61 EPS for the current fiscal year.

Insider Activity

In other news, CFO Jill G. Mcconnell sold 5,061 shares of the firm's stock in a transaction dated Tuesday, March 10th. The stock was sold at an average price of $9.07, for a total value of $45,903.27. Following the completion of the transaction, the chief financial officer directly owned 69,796 shares in the company, valued at $633,049.72. This trade represents a 6.76% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Insiders sold 9,673 shares of company stock valued at $92,242 in the last three months. Company insiders own 0.38% of the company's stock.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the company. Fifth Third Bancorp raised its position in Fortrea by 2,502.9% during the first quarter. Fifth Third Bancorp now owns 28,372 shares of the company's stock valued at $267,000 after acquiring an additional 27,282 shares in the last quarter. Counterpoint Mutual Funds LLC purchased a new position in Fortrea during the first quarter valued at approximately $291,000. Y Intercept Hong Kong Ltd purchased a new position in Fortrea during the first quarter valued at approximately $1,094,000. Strs Ohio raised its position in Fortrea by 42.7% during the first quarter. Strs Ohio now owns 69,500 shares of the company's stock valued at $655,000 after acquiring an additional 20,800 shares in the last quarter. Finally, Louisiana State Employees Retirement System purchased a new position in Fortrea during the first quarter valued at approximately $386,000.

Fortrea Company Profile

Fortrea, Inc is a global contract development and manufacturing organization (CDMO) that provides integrated solutions for pharmaceutical and biotechnology companies. Established as a spin-off from Thermo Fisher Scientific's Pharma Services business in October 2023, Fortrea leverages a legacy of scientific expertise and manufacturing scale to support drug development from early-stage research through commercial production. The company's comprehensive offerings address the complex needs of both small-molecule and biologics programs, making it a single source for clients seeking to accelerate timelines and manage costs.

Fortrea's core services encompass analytical and formulation development, process optimization, clinical and commercial manufacturing, and packaging services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.